Accueil   Diary - News   All news Adocia to Present New Clinical Data on BioChaperone® Technology

Adocia to Present New Clinical Data on BioChaperone® Technology

Lyon, France February 12th, 2019 – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of approved proteins, today announced that four abstracts featuring its BioChaperone® technology have been accepted for presentation at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) being held February 20-23, 2019 in Berlin, Germany.

 

Read the press release